menu search

United states steel corporation: not buying so close to the top

United States Steel Corporation's financials show it is still cheap despite beaten-down estimates, but the company's share price fluctuations make it ...

November 3, 2023, 3:54 pm

Trainline risk/reward is turning says jpmorgan ahead of results

Ahead of Trainline PLC's (LSE:TRN) interim results on Thursday, JPMorgan said the shares are now offering a fairer risk/reward as regulatory changes...

November 1, 2023, 8:38 am

Deal with u.a.w. won't put ford at a disadvantage, analysts say

A tentative agreement gives the United Automobile Workers union members at the carmaker their best terms in decades. But the cost to Ford will be mana...

October 26, 2023, 1:07 pm

Cvs health: rite aid's chapter 11 provides opportunity

CVS Health can derive strong synergy benefits from their pharmacies, health insurance, and PBM businesses. CVS Health's debt load is ...

October 22, 2023, 3:42 am

Credit quality has been manageable and within our expectations, says synovus ceo kevin blair

Synovus CEO Kevin Blair joins 'Squawk on the Street' to discuss the credit quality Synovus sees, how the higher rates have impacted Synovus' business,...

October 19, 2023, 1:10 pm

Match group: well-positioned for growth despite temporary headwinds

Match Group is undervalued at just 13 times forward earnings, offering a compelling opportunity to buy an industry leader at a discount. Match's unriv...

October 14, 2023, 5:40 am

Kronos bio presents positive preliminary data from phase 1 dose escalation portion of phase 1/2 kb-0742 study at aacr-nci-eortc

Demonstrated on-mechanism, single agent anti-tumor activity in heavily pre-treated patients with transcriptionally addicted solid tumors Showed ...

October 13, 2023, 4:30 pm

Alnylam: fda rejection of onpattro for attr-cm is a setback, but a manageable one

Despite a positive panel recommendation, the FDA rejected the Alnylam Pharmaceuticals, Inc. application to market Onpattro for ATTR-CM, citing a lack ...

October 10, 2023, 6:08 pm

My top under-appreciated dividend king to buy in october

Illinois Tool Works is laser-focused on margin expansion. The company has a healthy balance sheet and a manage...

October 8, 2023, 5:57 am

Fortive: interesting and well positioned conglomerate

Fortive Corporation's share price has remained largely stagnant since its spinoff from Danaher in 2016. The company's three segments focus on intellig...

October 5, 2023, 2:28 pm

Plains all american pipeline: a 7% yield protected by the permian basin

Plains All American Pipeline holds strong midstream positions inside the Permian Basin that connect to Houston, Corpus Christi, and Cushing. The compa...

October 4, 2023, 3:20 pm

Organon: the federal reserve black swan (rating upgrade)

The stock of junk-rated Organon & Co. has lost more than 40% since my first article, largely due to interest rates continuing to rise. I take a close ...

October 4, 2023, 11:45 am

Brandywine: one in the hand, two in the bush

Brandywine owns and manages a portfolio of office, life science/lab, residential, and mixed-use properties. The dividend yield is not safe but also un...

October 3, 2023, 2:26 am

Charles schwab: a tough third quarter coming up

Charles Schwab delivered solid second quarter results in tough market conditions, with manageable sales...

October 2, 2023, 7:05 am

Wall street expects medical properties trust stock to rise by 82%: here's why i disagree

Medical Properties Trust is facing an unmanageable debt load. Wall Street analysts are predicting a pro...

October 1, 2023, 9:37 am

Crawford united: m&a and efficiency efforts make it a buy

Crawford United Corporation has made appealing acquisitions, which could benefit its corporate valuation. The company has a solid balance sheet with a...

September 29, 2023, 11:30 pm

Dime community bancshares: as cheap as its name suggests

Dime Community Bancshares' stock has fallen significantly this year due to a decline in deposits and profitability, as well as concerns over the indus...

September 27, 2023, 10:21 pm

Royalty pharma: the time has come

Royalty Pharma offers a unique exposure in the pharmaceutical sector thanks to a diversified portfolio and lower operational risk vs. competitors. The...

September 27, 2023, 2:15 am

Goldman sachs 4 reasons higher oil prices merely a "manageable headwind" for us economy

Goldman Sachs says that while a sustained climb in oil prices could slow consumption and economic growth it will be a "...

September 25, 2023, 9:49 pm

Oil prices set to jump, but still 'manageable': goldman sachs

Goldman Sachs analysts predict oil prices will reach $100 per barrel, which could lead to higher gas prices for consumers but is not anticipated to be...

September 25, 2023, 5:50 pm


Search within

Pages Search Results: